(Q45219682)

English

A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).

scientific article published on 27 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

phase III clinical trial

0 references

author name string

Yuji Ueda

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Takashi Fujimura

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Shinichi Kinami

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Yasuo Hirono

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Akio Yamaguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Hiroyuki Naitoh

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Tohru Tani

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Masahide Kaji

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Hisakazu Yamagishi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Koichi Miwa

10

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)

11

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

27 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

519-522

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Tria

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL048

21 January 2018

PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL048

21 January 2018

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL048

21 January 2018

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL048

21 January 2018

Identifiers

10.1093/JJCO/HYL048

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45219682&oldid=810460932"